Medindia
Medindia LOGIN REGISTER
Advertisement

UltraShape Secures $15.1 Million in New Financing Led by Meritech Capital

Wednesday, September 5, 2007 General News
Advertisement
YOKNEAM, Israel and PALO ALTO, California, September 5 UltraShape, a global leader in non-invasive body contouring, today announcedit has completed a $15.1 million round of funding. The financing was led bynew investor Meritech Capital Partners, with participation from both of itsprevious institutional investors, Israel Seed Partners and Polaris VenturePartners.
Advertisement

"Our style of investing targets late-stage companies that are best inclass," said Rob Ward, a founder and managing director at Meritech. "We havebeen very impressed by UltraShape's technology, its ability to penetrateglobal markets and its management team, and are very confident thatUltraShape will maintain its leadership position in the field of non-invasivebody contouring solutions."
Advertisement

"We are very pleased to have Meritech join the UltraShape team," saidRodger Stewart, UltraShape President and CEO. "The infusion of capital willenable UltraShape to accelerate global market adoption to meet the growingdemands for our body contouring solution. We are confident that Meritech'sexperience and expertise will contribute significantly as UltraShape grows tobecome a global leader in the aesthetics industry."

About UltraShape

UltraShape is redefining aesthetic medicine by developing, manufacturingand marketing innovative non-invasive technologies for body contouring. Thecompany is dedicated to providing clinically proven safe and effectivesolutions that enhance the lives of patients worldwide. The UltraShapeproprietary non-invasive body contouring technology is based on focusedultrasound that targets and selectively disrupts fat cells without affectingsurrounding structures. Founded in 2000, UltraShape is a privately held andventure backed company with offices in the United States, Israel, France,United Kingdom, and Italy. The UltraShape system is not cleared by the FDAfor marketing in the United States. For more information visithttp://www.ultrashape.com.

About Meritech Capital Partners

Meritech Capital Partners is a leading provider of late-stage venturecapital to the most promising private technology companies. With over $2.2billion under management, Meritech seeks to lead investments in the portfoliocompanies of leading early-stage venture capital firms and looks forcompanies with proven and differentiated technology, rapidly-growing revenueand seasoned management teams. As one of the most active late-stageinvestors, Meritech provides guidance on a number of issues that rapidlygrowing companies typically face, including management incentive plans, IPOmarket timing and positioning, adviser selection, and post-IPO ownershiptransition. Meritech is located in Palo Alto, CA and can be found athttp://www.meritechcapital.com.Contacts: Abigail Marks UltraShape +972-4-909-9260 [email protected] Paula Moggio FischerHealth +1-310-577-7870 x151 [email protected] Jessica Fishman Gitam Porter Novelli +972-3-576-5798 [email protected]

SOURCE UltraShape Ltd.
Sponsored Post and Backlink Submission


Latest Press Release on General News

This site uses cookies to deliver our services.By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use  Ok, Got it. Close